Md Anderson Cancer Center At Cooper

Summary

Md Anderson Cancer Center At Cooper is a medical facility located in Camden, New Jersey. This center is recognized for care of Breast Cancer, Lung Cancer, Ovarian Cancer, Fallopian Tube Cancer, Cancer and other specialties. Md Anderson Cancer Center At Cooper is involved with conducting 58 clinical trials across 95 conditions. There are 10 research doctors associated with this hospital, such as David P. Warshal, Farhad Ravandi-Kashani, Jamin C. Morrison, and Kiran Naqvi.

Top PIs

Clinical Trials running at Md Anderson Cancer Center At Cooper

Breast Cancer

Lung Cancer

Skin Cancer

Melanoma

Cancer

Acute Promyelocytic Leukemia

Pneumonia

Ductal Carcinoma In Situ

Ductal Carcinoma

Radiation Pneumonitis

Elacestrant

for Breast Cancer

The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.

Recruiting

2 awards

Phase 3

3 criteria

Imlunestrant

for Early Breast Cancer

This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.

Recruiting

2 awards

Phase 3

6 criteria

Belzutifan + Fulvestrant

for Breast Cancer

The purpose of this study is to assess the efficacy and safety of belzutifan (MK-6482) plus fulvestrant compared to everolimus plus endocrine therapy (ET) (investigator's choice of fulvestrant or exemestane) in adults with estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) unresectable metastatic breast cancer. There is no formal hypothesis testing in this study.

Recruiting

1 award

Phase 2

6 criteria